Topic
Genetic Testing
10 Podcasts • 2 Cases • 1 Course on BackTable
Hear how experienced physicians approach Genetic Testing on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 67 • 18 Jun 2026
Bladder Cancer Risk Stratification: Best Practices
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes.
This podcast is supported by an educational grant from Johnson & Johnson.
More on Genetic Testing
Loading recent podcasts…
Tumor Board # 67
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
30+ listens
Urology # 308
Jun 11, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
860+ listens
Women's Health # 119
Jun 2, 2026
with Dr. Andrei Rebarber, Dr. Nicole Faulkner
How do you decide which noninvasive prenatal testing option is best for your patient, and when should you reach for...
390+ listens
Urology # 277
Nov 28, 2025
with Dr. Mark Tyson, Dr. Sarah Psutka, Dr. Vignesh Packiam
One of the most common dilemmas in urologic oncology: what do you do when a patient has T1 disease in both the bladder...
1,100+ listens
Urology # 310
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
780+ listens
Tumor Board # 65
Jun 11, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
100+ listens
Vascular & IR # 602
Dec 29, 2025
with Dr. Daniel DePietro, Dr. Venkatesh Krishnasamy
What considerations drive your decision between bland embolization, TACE, and radioembolization in managing...
2,200+ listens
Vascular & IR # 589
Nov 14, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee
As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking...
1,500+ listens
VI Case
Nov 21, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Tumor Board Case
Nov 11, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.